NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natural Resource Partners LP (NYSE: NRP ), Insmed, Inc. (NASDAQ: INSM ), MagnaChip Semiconductor Corporation (NYSE: MX ), Changyou.com Limited (NASDAQ: CYOU ), Pain Therapeutics (NASDAQ: PTIE ), and Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
NRP DOWNLOAD: http://Fundamental-Markets.com/register/?so=NRP INSM DOWNLOAD: http://Fundamental-Markets.com/register/?so=INSM MX DOWNLOAD: http://Fundamental-Markets.com/register/?so=MX CYOU DOWNLOAD: http://Fundamental-Markets.com/register/?so=CYOU PTIE DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTIE AUPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=AUPH
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Natural Resource Partners LP (NYSE: NRP ), Insmed, Inc. (NASDAQ: INSM ), MagnaChip Semiconductor Corporation (NYSE: MX ), Changyou.com Limited (NASDAQ: CYOU ), Pain Therapeutics (NASDAQ: PTIE ), and Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 15th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
NATURAL RESOURCE PARTNERS LP (NRP) REPORT OVERVIEW
Natural Resource Partners LP's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Natural Resource Partners LP reported revenue of $111.05MM vs $94.93MM (up 16.98%) and basic earnings per share $2.46 vs $1.47 (up 67.35%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Natural Resource Partners LP reported revenue of $378.02MM vs $400.06MM (down 5.51%) and basic earnings per share $5.06 vs $7.78 (down 34.96%). Natural Resource Partners LP is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $5.06 and is expected to report on March 7th, 2019.
To read the full Natural Resource Partners LP (NRP) report, download it here: http://Fundamental-Markets.com/register/?so=NRP
-----------------------------------------
INSMED, INC. (INSM) REPORT OVERVIEW
Insmed's Recent Financial Performance
Insmed is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.69. The estimated EPS forecast for the next fiscal year is -$3.06 and is expected to report on February 22nd, 2019.
To read the full Insmed, Inc. (INSM) report, download it here: http://Fundamental-Markets.com/register/?so=INSM
-----------------------------------------
MAGNACHIP SEMICONDUCTOR CORPORATION (MX) REPORT OVERVIEW
MagnaChip Semiconductor's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, MagnaChip Semiconductor reported revenue of $199.69MM vs $166.69MM (up 19.80%) and basic earnings per share -$0.62 vs -$0.24. For the twelve months ended December 31st, 2017 vs December 31st, 2016, MagnaChip Semiconductor reported revenue of $679.67MM vs $687.97MM (down 1.21%) and basic earnings per share $2.50 vs -$0.85. MagnaChip Semiconductor is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $0.70 and is expected to report on February 5th, 2019.
To read the full MagnaChip Semiconductor Corporation (MX) report, download it here: http://Fundamental-Markets.com/register/?so=MX
-----------------------------------------
CHANGYOU.COM LIMITED (CYOU) REPORT OVERVIEW
Changyou's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Changyou reported revenue of $112.83MM vs $150.36MM (down 24.96%) and basic earnings per share $0.60 vs $0.98 (down 38.78%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Changyou reported revenue of $580.26MM vs $525.39MM (up 10.44%) and basic earnings per share $2.06 vs $2.78 (down 25.90%). Changyou is expected to report earnings on October 26th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal year is $2.07 and is expected to report on February 4th, 2019.
To read the full Changyou.com Limited (CYOU) report, download it here: http://Fundamental-Markets.com/register/?so=CYOU
-----------------------------------------
PAIN THERAPEUTICS (PTIE) REPORT OVERVIEW
Pain Therapeutics' Recent Financial Performance
Pain Therapeutics is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.40.
To read the full Pain Therapeutics (PTIE) report, download it here: http://Fundamental-Markets.com/register/?so=PTIE
-----------------------------------------
AURINIA PHARMACEUTICALS INC (AUPH) REPORT OVERVIEW
Aurinia Pharmaceuticals' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Aurinia Pharmaceuticals reported revenue of $0.03MM vs $0.33MM (down 91.19%) and basic earnings per share -$0.19 vs -$0.03. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Aurinia Pharmaceuticals reported revenue of $0.42MM vs $0.17MM (up 142.77%) and basic earnings per share -$0.92 vs -$0.66. Aurinia Pharmaceuticals is expected to report earnings on November 13th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.75 and is expected to report on March 21st, 2019.
To read the full Aurinia Pharmaceuticals Inc (AUPH) report, download it here: http://Fundamental-Markets.com/register/?so=AUPH
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
